Evidence Hub

Sensitive Detection of Epidermal Growth Factor in Lung Cancer Patients by Electrochemical Biosensors

Valério TL, Hryniewicz BM, Basei FL, Araújo MSW, Jaradat H, Kanoun O, Carneiro FRG, Montella TC et al.

Analytical chemistry, 2026

Abstract

Lung cancer is the most common cancer worldwide, responsible for more deaths per year than any other cancer, with non-small cell lung cancer (NSCLC) being the most prevalent form. Elevated epidermal growth factor (EGF) levels have been associated with NSCLC and decreased survival, highlighting its potential as a prognostic and predictive biomarker. This study proposes developing and validating a novel impedimetric electrochemical biosensor for the sensitive and accurate detection of EGF in serum samples from patients with lung adenocarcinoma. The biosensor was constructed by electropolymerization of polypyrrole nanotubes (PPy-NTs) on screen-printed carbon electrodes, followed by the deposition of carboxylated multiwalled carbon nanotubes (MWCNT-COOH) used for the immobilization of biorecognition elements. Anti-EGF antibodies were covalently immobilized on the MWCNT-COOH-modified surface, and bovine serum albumin (BSA) was used to block nonspecific interactions. Electrochemical impedance spectroscopy (EIS) was employed to characterize each fabrication step and to detect EGF. The biosensor demonstrated a wide linear detection range from 500 fg mL-1 to 200 pg mL-1 with high linearity (R2 = 0.9924) and a remarkably low limit of detection (LOD) of 392 fg mL-1. The developed biosensor demonstrated excellent agreement with ELISA results, with a strong Pearson correlation (r = 0.865, p < 0.0001), and Bland-Altman analysis with 97.4% of the differences within the limits of agreement.…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free